trial

Effect of Memantine on ERP in Early Schizophrenia and Healthy Subjects

NCTId NCT02233556
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 20 (estimated)
Sponsored by National Taiwan University Hospital
Primary completion 2016-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
20 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2014-02
Primary completion
2016-12
Eligibility
ALL · 20 Years · 45 Years

Interventions & indications

Drugs
Memantine

Sponsors

National Taiwan University HospitalLead Sponsor

Investigators

1
Ming-Hsien Hsieh, MD, PhDPrincipal Investigator

Sites

1 total
Taipei, Taiwan

Facts & assertions

4 sourced
Enrollment
20
Phase
NA
Primary Completion Date
2016-12
Status
UNKNOWN
relationships
The graph out of here
drug
Memantine
drug
lead_sponsor
National Taiwan University Hospital
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Ming-Hsien Hsieh, MD, PhD
person